Robson Dossa

Robson Dossa is a seasoned professional in the biotechnology and pharmaceutical industries, currently serving as Vice President of Manufacturing and Quality at Arovella Therapeutics since March 2023, previously holding the position of Senior Director in the same department. Dossa has extensive experience at Instil Bio as Director of Early Stage Process Development and at Kite Pharma in various roles, including Associate Director of Allogeneic CAR-T. Dossa's earlier career includes a Postdoctoral Fellowship at Fred Hutch, focusing on T cell immunotherapy, and a tenure at Washington State University, where research ranged from vaccine development to immune response characterization. Dossa earned a Ph.D. from Washington State University and holds a Bachelor of Science in Molecular Biology from Universidade Federal de Pelotas.